Aniline

Aniline

SCHEMBL4264469

NOC(=O)c1cccc2ccccc12.Nc1ccccc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.55
NR4A2 P43354 1/20 0.55
NR4A3 Q92570 1/20 0.55
HPGD P15428 5/20 0.50
KDM4E B2RXH2 4/20 0.50
KMT2A Q03164 4/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
CDC25B P30305 2/20 0.49
MMP3 P08254 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
ALDH1A1 P00352 6/20 0.46
MEN1 O00255 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ATM Q13315 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
PTPN1 P18031 1/20 0.45
PLK1 P53350 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4404102 0.91 NR4A1 (0.59) NR4A1NR4A2NR4A3HPGDKDM4E
SCHEMBL28342585 0.90 NR4A1 (0.57) NR4A1NR4A2NR4A3HPGDKDM4E
SCHEMBL27615559 0.90 NR4A1 (0.57) NR4A1NR4A2NR4A3HPGDKDM4E
Naphthoic Acid SCHEMBL7570532 0.79 NR4A1 (0.81) NR4A1NR4A2NR4A3HPGDKDM4E
SCHEMBL29290132 0.79 KMT2A (0.60) NR4A1NR4A2NR4A3HPGDKDM4E
Benzene SCHEMBL28284945 0.78 NR4A1 (0.67) NR4A1NR4A2NR4A3HPGDKDM4E
SCHEMBL27797485 0.77 NR4A1 (0.59) NR4A1NR4A2NR4A3HPGDKDM4E
Hydrazine SCHEMBL28964205 0.77 NR4A1 (0.59) NR4A1NR4A2NR4A3HPGDKDM4E
SCHEMBL27810842 0.76 KMT2A (0.54) NR4A1NR4A2NR4A3HPGDKDM4E
SCHEMBL5987790 0.76 NR4A1 (0.63) NR4A1NR4A2NR4A3HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745022-B1 HISTONE DEACETYLASE INHIBITOR PRODRUGS ATON PHARMA INC (US) 2014-08-13 EP claimed
US-8227636-B2 Histone deacetylase inhibitor prodrugs MERCK HDAC RESEARCH, LLC (US) 2012-07-24 US claimed
EP-1745022-B1 HISTONE DEACETYLASE INHIBITOR PRODRUGS ATON PHARMA INC (US) 2014-08-13 EP disclosed
US-8227636-B2 Histone deacetylase inhibitor prodrugs MERCK HDAC RESEARCH, LLC (US) 2012-07-24 US disclosed
US-20090023786-A1 Histone Deacetylase Inhibitor Prodrugs ALTON PHARMA, INC. (US) 2009-01-22 US disclosed
EP-1745022-A1 HISTONE DEACETYLASE INHIBITOR PRODRUGS Aton Pharma, Inc. (US) 2007-01-24 EP disclosed
WO-2005097747-A1 HISTONE DEACETYLASE INHIBITOR PRODRUGS ATON PHARMA, INC. (US) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023786-A1 Histone Deacetylase Inhibitor Prodrugs HDAC1, HDAC5, HDAC7 NR4A1 2816/4885NR4A2 1997/4885NR4A3 1835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.